The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.
Chronic Nicotine Treatment Up-regulates Human α3β2 but Not α3β4 Acetylcholine Receptors Stably Transfected in Human Embryonic Kidney Cells
Open accessAbstract
Human nicotinic acetylcholine receptor (AChR) subtypes alpha3 beta2, alpha3 beta2 alpha5, alpha3 beta4, and alpha3 beta4 alpha5 were stably expressed in cells derived from the human embryonic kidney cell line 293. alpha3 beta4 AChRs were found in prominent 2-micrometer patches on the cell surface, whereas most alpha3 beta2 AChRs were more diffusely distributed. The functional properties of the alpha3 AChRs in tsA201 cells were characterized by whole cell patch clamp using both acetylcholine and nicotine as agonists. Nicotine was a partial agonist on alpha3 beta4 AChRs and nearly a full agonist on alpha3 beta2 alpha5 AChRs. Chronic exposure of cells expressing alpha3 beta2 AChRs or alpha3 beta2 alpha5 AChRs to nicotine or carbamylcholine increased their amount up to 24-fold but had no effect on the amount of alpha3beta4 or alpha3 beta4 alpha5 AChRs, i.e. the up-regulation of alpha3 AChRs depended on the presence of beta2 but not beta4 subunits in the AChRs. This was also found to be true of alpha3 AChRs in the human neuroblastoma SH-SY5Y. In the absence of nicotine, alpha3 beta2 AChRs were expressed at much lower levels than alpha3 beta4 AChRs, but in the presence of nicotine, the amount of alpha3 beta2 AChRs exceeded that of alpha3 beta4 AChRs. Up-regulation was seen for both total AChRs and surface AChRs. Up-regulated alpha3beta2 AChRs were functional. The nicotinic antagonists curare and dihydro-beta-erythroidine also up-regulated alpha3 beta2 AChRs, but only by 3-5-fold. The channel blocker mecamylamine did not cause up-regulation of alpha3 beta2 AChRs and inhibited up-regulation by nicotine. Our data suggest that up-regulation of alpha3 beta2 AChRs in these lines by nicotine results from both increased subunit assembly and decreased AChR turnover.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“If β4 replaces β2 subunits in either α3* or α4* nAChRs, receptor upregulation is significantly reduced (Wang et al. 1998; Sallette et al. 2004).”
From Nicotine Withdrawal (2015) · cites this paper as Wang et al. 1998
In the citing paper
“During prolonged exposure to nicotine, there is deceased receptor degradation (presumably via endocytosis), and this mechanism for upregulation must be considered as an adjunct to SePhaChARNS (8,39,66,87).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [87]
Citations
Cites
Hamill, O. P., Marty, A., Neher, E., Sakmann, B., & Sigworth, F. J. (1981) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00656997 · Cited by 18,436
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
The Diversity of Neuronal Nicotinic Acetylcholine Receptors
Sargent, P. B. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.002155 · Cited by 1,052
Wada, E., Wada, K., Boulter, J., Deneris, E. S., Heinemann, S., Patrick, J., & Swanson, L. W. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902840212 · Cited by 1,044
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
Nicotinic Receptors in the Development and Modulation of CNS Synapses
Role, L. W., & Berg, D. K. (1996) · Neuron · doi:10.1016/s0896-6273(00)80134-8 · Cited by 762
Molecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605
Pharmacology of Nicotine: Addiction and Therapeutics
Benowitz, N. L. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.003121 · Cited by 589
Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain
Benwell, M. E. M., Balfour, D. J. K., & Anderson, J. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10600.x · Cited by 551
Chavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., & Johnson, E. C. (1997) · PubMed · Cited by 392
Peng, X., Gerzanich, V, Anand, R., Whiting, P. J., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09730-5 · Cited by 391
Bannon, A. W., Decker, M. W., Holladay, M. W., Curzon, P., Donnelly‐Roberts, D. L., Puttfarcken, P. S., Bitner, R. S., Díaz, Á., Dickenson, A. H., Porsolt, R. D., et al. (1998) · Science · doi:10.1126/science.279.5347.77 · Cited by 368
The paradox of nicotinic acetylcholine receptor upregulation by nicotine
Wonnacott, S. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90242-z · Cited by 357
Assembly of Human Neuronal Nicotinic Receptor α5 Subunits with α3, β2, and β4 Subunits
Wang, F., Gerzanich, V., Wells, G. B., Anand, R., Peng, X.-D., Keyser, K. T., & Lindstrom, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17656 · Cited by 345
Self-citationVernallis, A. B., Conroy, W. G., & Berg, D. K. (1993) · Neuron · doi:10.1016/0896-6273(93)90333-m · Cited by 304
Gerzanich, V., Peng, X.-D., Wang, F., Wells, G. B., Anand, R., Fletcher, S. R., & Lindstrom, J. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10533-6 · Cited by 290
Self-citationMarshall, D. L., Redfern, P. H., & Wonnacott, S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041511.x · Cited by 284
In Vivo Regulation of [3H]Acetylcholine Recognition Sites in Brain by Nicotinic Cholinergic Drugs
Schwartz, R. D., & Kellar, K. J. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb04005.x · Cited by 282
Whiting, P. J., & Lindström, J. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-09-03395.1988 · Cited by 262
Gerzanich, V., Wang, F., Kuryatov, A., & Lindstrom, J. M. (1998) · PubMed · Cited by 242
Self-citationGrando, S. A., Horton, R. M., Pereira, E. F. R., Diethelm-Okita, B. M., George, P. M., Albuquerque, E. X., & Conti‐Fine, B. M. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12325606 · Cited by 210
Conroy, W. G., Vernallis, A. B., & Berg, D. K. (1992) · Neuron · doi:10.1016/0896-6273(92)90031-8 · Cited by 208
α-Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal Synaptosomes
Kulak, J. M., Nguyen, T. A., Olivera, B. M., & McIntosh, J. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05263.1997 · Cited by 198
Peng, X.-D., Gerzanich, V., Anand, R., Wang, F., & Lindstrom, J. M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.5.776 · Cited by 191
Self-citationPanning transfected cells for electrophysiological studies.
Margolskee, R. F., McHendry‐Rinde, B., & HORN, R. C. V. (1993) · PubMed · Cited by 186
Zia, S., Ndoye, A., Nguyen, V. T., & Grando, S. A. (1997) · PubMed · Cited by 178
Gopalakrishnan, M., Monteggia, L. M., Anderson, D. J., Molinari, E. J., Piattoni-Kaplan, M., Donnelly-Roberts, D., Arneric, S. P., & Sullivan, J. P. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12264-7 · Cited by 178
Tzartos, S. J., Hochschwender, S. M., Vasquez, P. P. D., & Lindstrom, J. M. (1987) · Journal of Neuroimmunology · doi:10.1016/0165-5728(87)90092-0 · Cited by 175
Self-citationOlale, F., Gerzanich, V., Kuryatov, A., Wang, F., & Lindstrom, J. M. (1997) · PubMed · Cited by 172
Self-citationStable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor
Gopalakrishnan, M., Buisson, B., Touma, E., Giordano, T., Campbell, J. E., Hu, I. C., Donnelly‐Roberts, D. L., Arnerić, S. P., Bertrand, D., & Sullivan, J. P. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)00083-6 · Cited by 172
Kaiser, S., Soliakov, L. S., Harvey, S. C., Luetje, C. W., & Wonnacott, S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70031069.x · Cited by 160
Grando, S. A., Horton, R. M., Mauro, T. M., Kist, D. A., Lee, T. X., & Dahl, M. V. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12363399 · Cited by 156
Flores, C. M., Dávila‐García, M. I., Ulrich‐Lai, Y. M., & Kellar, K. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052216.x · Cited by 142
Whiting, P. J., Liu, R., Morley, B., & Lindstrom, J. M. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-12-04005.1987 · Cited by 138
Self-citationCampos‐Caro, A., Smillie, F. I., del Toro, E. D., Rovira, J. C., Vicente‐Agulló, F., Chapuli, J., Juiz, J. M., Sala, S., Sala, F., Ballesta, J. J., et al. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020488.x · Cited by 131
Horch, H., & Sargent, P. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-12-07778.1995 · Cited by 127
Gopalakrishnan, M., Molinari, E. J., & Sullivan, J. P. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.524 · Cited by 127
Pauly, J. R., Marks, M. J., Robinson, S. F., van de Kamp, J. L., & Collins, A. C. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20143-4 · Cited by 126
Ullian, E. M., McIntosh, J. M., & Sargent, P. B. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-19-07210.1997 · Cited by 118
Chini, B., Clementi, F., Hukovic, N., & Sher, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1572 · Cited by 109
Maimone, M. M., & Merlie, J. P. (1993) · Neuron · doi:10.1016/0896-6273(93)90270-2 · Cited by 107
Blount, P., Smith, M. M., & Merlie, J. P. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.6.2601 · Cited by 102
Hsu, Y., Αmin, J., Weiss, D. S., & Wecker, L. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020667.x · Cited by 87
(1990) · doi:10.1093/oso/9780192616142.001.0001 · Cited by 75
Cyclic AMP-dependent phosphorylation of a neuronal acetylcholine receptor alpha-type subunit
Vijayaraghavan, S., Schmid, H., Halvorsen, S. W., & Berg, D. K. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03255.1990 · Cited by 61
Cohen, B. N., Figl, A., Quick, M. W., Labarca, C. G., Davidson, N., & Lester, H. A. (1995) · The Journal of General Physiology · doi:10.1085/jgp.105.6.745 · Cited by 50
Shyng, S. L., Xu, R., & Salpeter, M. M. (1991) · Neuron · doi:10.1016/0896-6273(91)90254-w · Cited by 48
Green, W. N., Ross, A. F., & Claudio, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.854 · Cited by 46
Mihovilovic, M., & Roses, A. D. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6517 · Cited by 43
Molecular and Antigenic Structure of Nicotinic Acetylcholine Receptors
Lindstrom, J. M., Peng, X.-D., Kuryatov, A., Lee, E. B., Anand, R., Gerzanich, V., WANG, F., Wells, G. B., & NELSON, M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10910.x · Cited by 36
Self-citationStetzer, E., Ebbinghaus, U., Storch, A., Poteur, L., Schrattenholz, A. S., Kramer, G., Methfessel, C., & Maelicke, A. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01115-5 · Cited by 27
Depression, smoking, and nicotine: Toward a bioinformational situation by trait model
Gilbert, D. G. (1996) · Drug Development Research · doi:10.1002/(sici)1098-2299(199607/08)38:3/4 · Cited by 25
Wheeler, S. V., Jane, S. D., CROSS, K. M. L., Chad, J. E., & Foreman, R. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051891.x · Cited by 13
Research works printed but not linked: 13
- Lindstrom, 1996, 4, 377
- Zia, 1997, Res. Commun. Mol. Pathol. Pharmacol., 97, 243
- Gerzanich, 1995, Mol. Pharmacol., 48, 774
- Olale, 1997, J. Pharmacol. Exp. Ther., 283, 675
- Stauderman, 1998, J. Pharmacol. Exp. Ther., 284, 77
- Pauly, 1996, J. Pharmacol. Exp. Ther., 278, 361
- Wonnacott, 1996, Drug Dev. Res., 38, 149, 10.1002/(SICI)1098-2299(199607/08)38:3/4<149::AID-DDR3>3.0.CO;2-M · DOI
- Peng, 1994, Mol. Pharmacol., 46, 523
- Gopalakrishnan, 1996, J. Pharmacol. Exp. Ther., 276, 289
- Margolskee, 1993, BioTechniques, 15, 906
- Gerzanich, 1998, J. Pharmacol. Exp. Ther., 286, 311
- Chavez-Noriega, 1997, J. Pharmacol. Exp. Ther., 280, 346
- Pauly, 1996, J. Pharmacol. Exp. Ther., 278, 361
Cited by
Sorted by citations
Desensitization of neuronal nicotinic receptors
Quick, M. W., & Lester, R. A. J. (2002) · Journal of Neurobiology · doi:10.1002/neu.10109 · Cited by 456
Cellular and synaptic mechanisms of nicotine addiction
Mansvelder, H. D., & McGehee, D. S. (2002) · Journal of Neurobiology · doi:10.1002/neu.10148 · Cited by 450
Cue dependency of nicotine self-administration and smoking
Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., Hoffman, A., Perkins, K. A., & Sved, A. F. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00676-1 · Cited by 444
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.332 · Cited by 422
Self-citationCellular mechanisms of nicotine addiction
Dani, J. A., & De Biasi, M. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00652-9 · Cited by 408
Metadata
- Authors
- Wang, F., Nelson, M. E., Kuryatov, A., Olale, F., Cooper, J., Keyser, K., & Lindstrom, J.
- Affiliations
- University of Pennsylvania (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Lindstrom, Jon
- ORCID
- Nelson, Mark E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-11
- Volume
- 273
- Issue
- 44
- Pages
- 28721-28732
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2052494845
- Cited by
- 187
- References
- 56
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 12 · 2014: 4 · 2013: 6 · 2012: 1
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS11323, F32NS010333, R01NS011323, NS10333)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotinic acetylcholine receptors, receptor up-regulation, chronic nicotine exposure, receptor subunit assembly, receptor turnover, partial agonism, nicotinic antagonists, mecamylamine, curare, dihydro-beta-erythroidine, SH-SY5Y cells, tsA201 cells
- MeSH terms
- Animals, Cell Line, Humans, Mecamylamine, Nicotine, Receptors, Cholinergic, Transfection, Xenopus laevis, Up-Regulation, Cholinergic Agonists, Cholinergic Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review